What is zolpidem?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Zolpidem?

Zolpidem is a non-benzodiazepine sedative-hypnotic medication (commonly known as a "Z-drug") used for the short-term treatment of insomnia, specifically to help adults fall asleep faster. 1

Mechanism of Action

Zolpidem works as a GABA-A receptor positive modulator, binding preferentially to the benzodiazepine site of α1 subunit-containing GABA-A receptors 1. This selective binding increases chloride channel opening frequency, which inhibits neuronal excitation and induces sleep. Unlike traditional benzodiazepines, zolpidem's selectivity for α1 receptors (versus α2, α3, and α5 subunits) explains why it produces sedation with relatively less muscle relaxation, anticonvulsant effects, and anxiolytic properties 1, 2.

Pharmacokinetics

  • Rapid absorption: Peak concentrations occur at approximately 1.6 hours after oral administration
  • Short half-life: 2.5-2.6 hours in healthy adults
  • Protein binding: 92.5%
  • Metabolism: Converted to inactive metabolites eliminated primarily through kidneys 1

Food significantly delays absorption - taking zolpidem with or immediately after meals decreases peak concentration by 25% and delays time to peak effect by 60%, so it should be taken on an empty stomach for optimal effect 1.

FDA-Approved Dosing

The FDA issued sex-specific dosing recommendations in 2013 based on pharmacokinetic differences:

  • Women: 5 mg immediate-release (6.25 mg extended-release)
  • Men: 10 mg immediate-release (12.5 mg extended-release)
  • Elderly patients (both sexes): 5 mg maximum 3, 1

These sex-differentiated doses reflect that women metabolize zolpidem more slowly, leading to higher next-day blood levels and greater impairment risk 3.

Clinical Use

Zolpidem is indicated for short-term treatment only (typically 7-10 days) 1. It should be:

  • Taken immediately before bedtime
  • Used only when able to stay in bed for a full 7-8 hours
  • Limited to one tablet per night
  • Not combined with alcohol or other sedatives 1

Serious Safety Concerns

Complex Sleep Behaviors (Black Box Warning)

The most critical safety issue is complex sleep behaviors - activities performed while not fully awake that the person doesn't remember the next morning 1, 4. These include:

  • Sleep-driving
  • Sleep-eating
  • Making phone calls
  • Having sex
  • Sleep-walking

These behaviors have caused serious injuries and deaths. Zolpidem is contraindicated in anyone who has previously experienced such behaviors 1.

Neuropsychiatric Effects

Recent evidence highlights significant neuropsychiatric adverse effects, particularly:

  • Hallucinations and perceptual disturbances
  • Amnesia
  • Altered states of consciousness that have led to criminal charges in some cases 4

Risk is highest in women, elderly patients, those with psychiatric comorbidities, and patients on polypharmacy 4.

Next-Day Impairment

The 2013 FDA warning specifically addressed driving impairment the morning after use, with blood levels remaining high enough to impair cognition and motor function, especially in women 3.

Dependence and Withdrawal

Despite being marketed as having lower dependence risk than benzodiazepines, zolpidem can cause significant dependence and withdrawal symptoms, including generalized seizures 5. This is particularly problematic given widespread chronic use despite recommendations for short-term treatment only 5, 6.

Special Populations

  • Elderly: Require 50% dose reduction due to 64% higher drug exposure and 32% longer half-life 1
  • Pregnancy: Limited safety data; use during third trimester may cause respiratory depression and excessive sleepiness in newborns 1, 7
  • Breastfeeding: Passes into breast milk 1

Controlled Substance Status

Zolpidem is a Schedule IV controlled substance due to abuse and dependence potential 1.

References

Research

Bottom-Up versus Top-Down Induction of Sleep by Zolpidem Acting on Histaminergic and Neocortex Neurons.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016

Guideline

patterns of zolpidem use in male and female veterans following revised fda dosing guidelines.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018

Research

Zolpidem dependence and withdrawal. A case report of generalized seizures.

Revista Colombiana de psiquiatria (English ed.), 2023

Research

[The use of zolpidem in the treatment of acute and chronic insomnia].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2025

Research

How do you Zzz during pregnancy? A brief review of Z-drug use and management of insomnia during pregnancy.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.